×

What are you searching for?




Press Release

4 Min read

Intrathecal Drug Delivery System Market to Grow at 5.2% CAGR during 2021-2029, Owing to Investments towards Technological Advancements, Reports Absolute Markets Insights

Published On 26 Aug 2021 12:44 PM


SHARE THIS ARTICLE  


Intrathecal drugs delivery (IDD) system is useful in the treatments of intractable (uncontrollable) pain. IDD system is utilized for providing medical treatment to patients who have medical conditions that make health so fragile that patients do not have options of any other treatment. Medical treatment through IDD requires highly specialized team that can ensure not only appropriate selection but also safety criteria. The major factor driving the growth of global intrathecal drug delivery system market is the rising prevalence of cancer all over the world. Due to prevalence of cancer, the demand for IDD system is increasing. Extensively improved analgesia is also expected to boost the market growth. The less adverse effects of IDD system compared to traditional opioid-based treatments (using morphine and drugs like morphine), make it a preferable option regarding pain management and many types of medical treatment.

Request a sample Copy@

https://www.absolutemarketsinsights.com/request_sample.php?id=874

Growing demand for information technology (IT) therapy is an opportunity that can play a positive role in the global intrathecal drug delivery system market. There are software which can monitor the amount of drug being injected to patient and display the findings on a screen. The growing investments by companies into research and development activities exploring possibilities regarding IDD are in progress and many doctors are making efforts to develop an effective as well as advanced pain management solution. Such solutions are anticipated to amplify the growth of global intrathecal drug delivery system market over the period of next eight years.

Enquiry Before Buying@ https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=874

Key Findings of the Report:

  • The global intrathecal drug delivery system market was valued at US$ 900.96 Mn in 2020 and is anticipated to reach US$ 1415.96 Mn by 2029 growing at a CAGR of 5.2% during the forecast period (2021 – 2029)
  • In order to cope up with rising cancer cases, the intrathecal drug delivery system has proven to be more effective than oral medications. As a drug delivery platform, the pump delivers a variety of medication to treat unavoidable cancer pain. The system enables immediate release of medication into the fluid surrounding the spinal cord and reaches the nerves that are responsible for the perception of pain.
  • Intrathecal drug delivery systems provide pain relief as they directly infuse medication into the cerebrospinal fluid. An IDD system includes the mechanical device that stores the analgesic medication and the catheter that infuses it. The intrathecal infusion of analgesics has been treating patients with chronic pain for more than 20 years. It is refractory to many conventional therapies.
  • The global intrathecal drug delivery system market participants are increasingly studying the efficacy of intrathecal drug delivery for non-cancerous diseases in individuals. Medtronic, for instance, conducted clinical trials for studying the impact of intrathecal drug delivery for the treatment of chronic intractable non-malignant primary back pain.
  • Patients are increasingly opting for targeted drug delivery options, especially in the advanced economies where there is a higher awareness about this system. Simultaneously, the companies are increasingly working towards the reduction of complications associated with intrathecal drug delivery.
  • In 2020, North America was the biggest regional market in the global intrathecal drug delivery system market. Factors such as technological advancement, advanced medical facilities, availability of better healthcare facilities, and presence of many key market players have contributed towards the region’s highest share in the global market.
  • Some of the major players operating in the global intrathecal drug delivery system market are Alcyone Lifesciences, B. Braun Melsungen AG, Flowonix, Medtronic, Smiths Group PLC, and Tricumed Medizintechnik GmbH.

Request for Customization@ https://www.absolutemarketsinsights.com/request_for_customization.php?id=874

Global Intrathecal Drug Delivery System Market:

  • By Offering
    • Pump
    • Catheter
    • Trays and Kits
    • Others
  • By Type
    • Pain Management
      • Malignant
      • Non-Malignant
    • Spasticity Management
  • By End user
    • Hospital
    • Clinics
    • Ambulatory Surgical Centers
    • Others
  • By Medications
    • Morphine
    • Ziconotide
    • Baclofen
    • Non-opioid medications, such as resiniferatoxin
    • Others
  • By Clinical Indications
    • Chronic back and neck pain
    • Sciatica
    • Chronic abdominal pain
    • Failed back and neck surgery
    • Central nervous system
    • Cancer
    • Reflex sympathetic dystrophy or complex regional pain syndrome
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
      • Rest of North America
    • Europe
      • France
      • The UK
      • Spain
      • Germany
      • Italy
      • Nordic Countries
        • Denmark
        • Finland
        • Iceland
        • Sweden
        • Norway
      • Benelux Union
        • Belgium
        • The Netherlands
        • Luxembourg
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • New Zealand
      • Australia
      • South Korea
      • Southeast Asia
        • Indonesia
        • Thailand
        • Malaysia
        • Singapore
        • Rest of Southeast Asia
      • Rest of Asia Pacific
    • Middle East & Africa
      • Saudi Arabia
      • UAE
      • Egypt
      • Kuwait
      • South Africa
      • Rest of Middle East & Africa
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America

For More Information Click@ https://www.absolutemarketsinsights.com/reports/Intrathecal-Drug-Delivery-System-2021---2029-874

About Us:

Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.
 

Contact Us:

Company: Absolute Markets Insights
Email id: [email protected] 
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
The Work Lab,Model Colony, Shivajinagar, Pune, MH, 411016
Website: https://www.absolutemarketsinsights.com/


SHARE THIS ARTICLE  

Press Release Provided By: Absolute Markets Insights